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Abstract: The study of pathway disruption is key to understanding cancer biology. Advances in high throughput technologies 
have led to the rapid accumulation of genomic data. The explosion in available data has generated opportunities for inves-
tigation of concerted changes that disrupt biological functions, this in turns created a need for computational tools for 
pathway analysis. In this review, we discuss approaches to the analysis of genomic data and describe the publicly available 
resources for studying biological pathways.
Background
The development of cancer involves the accumulation of genetic and epigenetic alterations. Genetic 
events such as chromosomal rearrangements, changes in gene dosage, and sequence mutations can 
inﬂ  uence gene expression patterns, which contribute to the hallmark phenotypes of cancer
1,2. The inter-
action between pathways and the involvement of pathways in multiple phenotypes complicate the 
interpretation of gene expression patterns. For example, the epidermal growth factor receptor (EGFR, 
HER1, ERBB-1) signaling pathway plays a role in speciﬁ  c phenotypes including resistance to apopto-
sis, increased proliferation, mitogenesis, transcription of numerous target genes, and actin reorganiza-
tion, in several cancers (Fig. 1)
1,3,4. In order to decipher the interaction within and between pathways, 
computational tools are necessary to annotate components, to identify co-regulated expression, and to 
identify sets of genes or pathways which are statistically over/under-represented within a dataset.
Methods for Gene Classiﬁ  cation
A major analytical step to mine large microarray data is sample classiﬁ  cation or identiﬁ  cation of gene 
sets with characteristic biological function. Entrez Gene at the National Center for Biotechnology 
Information (NCBI) provides unique identiﬁ  ers for genes, and is a searchable database providing gene-
speciﬁ  c information and links to external databases, including the Gene Ontology (GO) consortium, 
KEGG and Reactome
5. A limitation of Entrez Gene is that genes are searched individually, which could 
be time consuming. Here, we describe the Gene Ontology (GO), a structural language to annotate gene 
functions for batch processing, and also methods of clustering analysis. The algorithmic basis of clus-
tering identiﬁ  es a pattern associated in a data set, which could be subsequently followed by GO analy-
sis to identify its underlying biology.
Gene Ontology annotation
The Gene Ontology (GO) Consortium was established in 2000 to provide a controlled vocabulary 
for annotating homologous gene and protein sequences in different organisms
6,7. GO classiﬁ  es genes 
and gene products based on three hierarchical structures that describe a given entry’s biological 
processes, cellular components, and molecular functions, and organizes them into a parent-child 
relationship
6. Through easy on-line access (http://www.geneontology.org), the genome databases 
are being uniﬁ  ed to expedite the process of retrieving information on genes and proteins based on 
shared biology among multiple organisms. Several software tools, including GoMiner
8,9, 380
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MAPPFinder
10, and Onto-Express
11,12, have been 
developed to explore the GO relationships among 
high-throughput data. However, the biological 
functions of genes/proteins are often complex 
and annotating them into categories may over-
simplify their biology. The ﬂ  at-format output 
does not convey the richness of GO’s hierarchi-
cal structure. Nevertheless, this established sys-
tem of nomenclature of genes and proteins is 
important for the interoperability of databases, 
batch processing, and the future design of 
pathway databases.
Clustering
The biological system is integrative with tightly 
regulated processes, and genes with similar 
functions often exhibit coordinated expression pat-
terns
13–16. Transcriptional proﬁ  ling studies typically 
aim to identify patterns of change among clinically 
related samples or to classify subgroups of 
samples
15–17. Clustering of microarray data is widely 
used to identify groups of genes that display coor-
dinated expression patterns performed in a super-
vised or unsupervised manner (Fig. 2)
13,14,17–21. 
Unsupervised clustering is to classify data without 
a priori labeling of samples, whereas supervised 
clustering classiﬁ  es data based on knowledge of 
samples type (e.g. cancer subtype)
21–24. Clustering 
techniques are generally classiﬁ  ed into two types: 
hierarchical and partitional
25,26. Hierarchical clus-
tering is constructed by either agglomerative 
(bottom-up) or divisive (top-down) approaches
25. 
Agglomerative algorithms begin with separate 
clusters and merge them into successively larger 
clusters, while divisive algorithms begin with the 
whole dataset and divide the data into smaller clus-
ters successively
25. The output of agglomerative 
clustering is a tree of clusters called a dendrogram, 
in which each branch represents group of genes that 
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Figure 1. Example of EGFR-mediated signaling changes, a commonly disrupted pathway in lung cancer. The EGFR pathway could be 
disrupted by an increased expression of growth factor ligands. By targeting EGFR with tyrosine kinase inhibitors (TKIs) and MAb (monoclo-
nal antibodies), EGFR activity can be eliminated. However, a downstream factor (e.g. MAPK signaling pathway) may also be activated to 
disrupt the pathway, thus making TKIs ineffective. Pathway data was obtained and selected from the Cancer Cell Map database and drawn 
using Cytoscape.381
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have a higher order relationship (Fig. 2B)
25,27. 
Partitional clustering directly reduces the dataset 
into a set of non-overlapping clusters
26. Represen-
tative algorithms of partitional clustering include 
k-means clustering and self-organizing maps 
(SOM)
25. k-means clustering requires the user to 
deﬁ  ne k number of clusters
26,28, and SOM partitions 
data into a two dimensional grid of clusters
13,29,30. 
However, hierarchical clustering is more frequently 
used
17–20,30. Detailed reviews of clustering algo-
rithms are available and this topic will not be dis-
cussed further in this review
26,31–33.
Dimensionality reduction
Dimensionality reduction of data is used to 
minimize the number of input variables for ﬁ  nding 
coherent patterns of gene expression in an efﬁ  cient 
manner
25,34,35. Algorithms like principle compo-
nent analysis (PCA) and multi-dimensional scaling 
(MDS) both employ this technique for classiﬁ  ca-
tion procedures
25,34,36,37. PCA visualizes multi-
dimensional datasets by projecting data into a 
sub-space with 2 or 3 dimensions (Fig. 2C)
34,35,37,38. 
The three-dimensional graphical display of MDS 
can be useful to portray relationships among the 
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Figure 2. Graphical output display of heatmap, hierarchical clustering, and principal component analysis. A: An example of a heatmap 
representation of 30 simulated proﬁ  les helps the user to easily visualize four groups of samples along the x-axis with distinct characteristics 
expression patterns for 300 genes. Heatmap facilitates the grouping of altered genes and sample clusters, but does not convey any spatial 
relationship between clustered samples. B: An example of a dendrogram generated from hierarchical clustering of the simulated data rep-
resented in ﬁ  gure 2A. A dendrogram is a tree diagram consisting of many U-shaped lines connecting objects to represent hierarchical 
clusters. In this dendrogram, four clusters of samples are formed based on distinct expression signatures. C: A two-dimensional graphical 
visualization of principal components analysis (PCA) based on the simulated data shown in ﬁ  gure 2A. Samples are color-coded based on 
the four clusters observed by hierarchical clustering in 2B.382
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data points but might be complex to interpret and 
require subjective judgments.
Classiﬁ  cation analysis may provide some pat-
tern to the experimental datasets. Subsequently, 
the identiﬁ  ed pattern may be further evaluated for 
biological interpretation using tools such as GO 
and/or Entrez Gene. However, the inherent limita-
tion of pre-processed databases is subjective to the 
interpretation of the curator. Therefore, further 
validation should be considered. In a study that 
was conducted under the hypothesis that members 
in the same cluster would share related biological 
annotations, the majority of the clusters generated 
by three different clustering algorithms do not cor-
respond well with known biology
39. Furthermore, 
there is a need to improve the different clustering 
algorithms to enhance consistency of the results
39,40. 
It is crucial to associate biological functions or 
regulatory pathways with each identiﬁ  ed cluster 
of genes in order to deduce biological signiﬁ  cance 
to each sample group
41.
Construction of Pathway Database
A remarkable number of published articles have 
collectively yielded thousands of molecular inter-
actions for human and for model species. The 
challenge is to extract these individual interactions 
from the literature and to comprehend the dynamics 
of the interlocking networks as a whole. In recent 
years, massive efforts have been devoted to manag-
ing, integrating, and interpreting the available 
scientiﬁ  c information in a meaningful manner 
(i.e. building interactomes or networks of genes 
and pathways)
42,43. Three categories of information 
are essential for the construction of interactome 
databases: gene and protein sequences, gene and 
protein biological information, and molecular 
interaction resources (Fig. 3). The major reposito-
ries of genes and protein sequences are listed in 
Table 1. Examples of nucleotide sequence data-
bases include NCBI GenBank, EMBL, and DDBJ, 
all of which are part of the International Nucleotide 
Sequence Database Collaboration to facilitate data 
exchange and enhance accuracy
44–47. The major 
databases for gene and protein biological informa-
tion are listed in Table 2. Gene Ontology (GO), 
OMIM, Entrez Gene, and Universal Protein 
Resource Knowledgebase (UniProtKB) are the 
foundation for building these hierarchical data-
bases
5,7,48,49. The main publicly available molecu-
lar interaction databases are listed in Table 3. 
Currently, DIP, IntAct, MINT, HPRD, and MIPS 
all support the Human Proteome Organization 
(HUPO) Proteomics Standards Initiative Molecu-
lar Interaction (PSI-MI) standard format
50–55. This 
is a uniﬁ  ed data standard to represent molecular 
interaction data in a controlled vocabulary, which 
facilitates data comparison, exchange, and linking 
queries together
51.
The wealth of biological resources can compli-
cate the construction of pathway databases 
(Fig. 4). When assembling information into a 
pathway database, developers must be cautious to 
Pathway
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Figure 3. Biological knowledgebases contain a myriad of speciﬁ  c information on each gene/protein. Sequence databases are the basis for 
gene and protein information. Gene and protein information is further extracted and their inter-relationships are experimentally identiﬁ  ed, 
building molecular interaction databases. All of this information is the foundation of pathway databases.383
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Table 1. Gene and protein databases.
Database Full name Comments Website Ref
NCBI Gen-
Bank
NIH genetic 
sequence data-
base
An international DNA sequence 
database
www.ncbi.nlm.nih.gov/
Genbank
[45]
EMBL Nucle-
otide 
Sequence 
Database/ 
EMBL-Bank
European Molecu-
lar Biology Labora-
tory Nucleotide 
Sequence Data-
base
Collection of DNA and RNA 
sequences in Europe and is syn-
chronized with GenBank at NCBI 
and DDBJ in Japan. 
www.ebi.ac.uk/embl [46]
DDBJ DNA Data Bank of 
Japan
Nucleotide sequence database in 
Japan and in collaboration with 
EMBL and NCBI GenBank
www.ddbj.nig.ac.jp [47]
Entrez Gene - NCBI database that focuses on 
gene-to-sequence relationship and 
provides gene-speciﬁ  c information. 
www.ncbi.nlm.nih.gov/
entrez/query.
fcgi?db=gene
[5]
RefSeq NCBI Reference 
Sequences
NCBI collection of non-redundant 
set of DNA, RNA, and protein 
sequences. 
www.ncbi.nlm.nih.gov/
RefSeq
[72]
UniGene NCBI UniGene Partitions GenBank sequences into 
sets of transcript sequences that 
are likely to represent distinct 
genes. 
www.ncbi.nlm.nih.gov/
entrez/query.
fcgi?db=unigene
[73]
Ensembl - A source for comparative chordate 
genome sequences and gene 
annotation at EBI/Sanger. 
www.ensembl.org [74]
UCSC 
Genome 
Browser 
Database
University of 
California Santa 
Cruz Genome 
Browser Database
Human genome assembly and 
customizable track browsers at 
UCSC. 
genome.ucsc.edu/
bestlinks.html
[75]
UniProtKB/
TrEMBL
Universal Protein 
Resource Knowl-
edgebase/ Trans-
lated European 
Molecular Biology 
Laboratories
Computer-curated protein sequence 
database containing translations of 
all coding sequences in EMBL/
GenBank/DDBJ and also other 
protein sequences from the litera-
ture. 
www.ebi.ac.uk/trembl [49]
UniProtKB/
Swiss-Prot 
Protein 
Knowledge-
base
Universal Protein 
Resource Knowl-
edgebase 
Manually-curated protein sequence 
database providing publicly avail-
able information about protein 
sequences. 
www.ebi.ac.uk/swis-
sprot
[49]
distinguish those interactions that are deduced from 
hypothetical situations from those that have been 
experimentally conﬁ  rmed. Within the latter group, 
care must also be taken to determine whether 
interactions have been conﬁ  rmed in a single direct 
experiment or a high-throughput experiment. Fur-
thermore, the use of natural language processing 
(NLP) systems to automate the extraction of 
information from published articles and to identify 
relationships between gene and protein names or 
interactions must be reviewed for biological rel-
evance
56,57. This method is useful as a ﬁ  rst-pass 
tool for mining and extracting the knowledge in 
the literature. However, the constantly advancing 
nature of research, the further reﬁ  nement of bio-
logical knowledge associated with each gene or 384
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] protein further reﬁ  ning, the incompletion of the 
annotation database, and the complexity of entity 
names in the biological domain often makes it 
challenging for NLP to be high-quality with huge 
successes.
Descriptions of Speciﬁ  c Pathway 
Database
Pathway databases facilitate the data mining pro-
cess for cancer researchers. The major pathway 
databases are listed in Table 4. A collection of 
biological pathway and network databases is sum-
marized in Table 5, including Pathguide: The 
Pathway Resource List (http://www.pathguide.
org)
58. This website is updated regularly and cur-
rently about 224 biological pathway resources are 
accessible through the Pathguide website. Here, 
we focus on a subset of databases that are publicly 
available.
KEGG
The KEGG (Kyoto Encyclopedia of Genes and 
Genomes) database has been established since 1995 
and has been one of the most popular knowledge 
databases to date
59. The KEGG PATHWAY database 
consists of manually assembled pathway maps based 
on inspection of published literature. Pathway maps 
are grouped into metabolism, genetic information 
processing, environmental information processing, 
cellular processes, human diseases, and drug devel-
opment. Most of the pathways associated with 
cancer are listed in the environmental information 
processing section, which is further subdivided into 
membrane transport, signal transduction, and 
signaling molecules and interaction. Beside human 
databases, information from other model organisms 
such as chimpanzee, mouse, rat, dogs, cows, and 
pigs is also available. KEGG pathway maps can be 
manipulated through the KEGG Markup Language 
(KGML) ﬁ  les, which provide graphical information 
to customize pathways.
The Cancer Cell Map
The Cancer Cell Map (http://cancer.cellmap.org) 
is the only database that focuses on signaling 
pathways implicated in cancer. This resource 
contains ten cancer-related pathways and each 
pathway has approximately 100 to 400 interac-
tions. Interactions are manually curated and 
reviewed for biological validity. Extensive 386
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Table 3. Molecular interaction database.
Database Full name Comments Visualization 
capability
Website Ref
IntAct EBI protein 
intearction 
database
Protein interaction database by 
literature curation or user 
submissions. 
HierarchView www.ebi.ac.uk/intact/
site/index.jsf
[52]
DIP Database of 
Interacting 
Proteins
Curated both manually and 
automatically to combine 
experimentally determined 
protein-protein interactions. 
Y dip.doe-mbi.ucla.edu [50]
MINT Molecular INTer-
actions Database
Curated manually, experimen-
tally veriﬁ  ed protein interac-
tions from literature. 
MINT Viewer mint.bio.uniroma2.it/
mint/Welcome.do
[53]
HPRD Human Protein 
Reference 
Database
Manually curated based on 
experimental evidence and 
contains information on domain 
architecture, post-translational 
modiﬁ  cations, interaction 
networks and disease associa-
tion.
GenMAPP www.hprd.org [54]
HomoMINT - Molecular interactions discov-
ered in model organisms are 
mapped to orthologs in Homo 
sapiens. 
MINT Viewer mint.bio.uniroma2.it/
HomoMINT
[90]
Domino Domain peptide 
interactions 
database
Protein interactions of domain 
peptides. 
MINT Viewer mint.bio.uniroma2.it/
domino
[91]
PDZBase - Experimentally determined 
protein-protein interactions 
involving the PDZ-domains. 
N icb.med.cornell.edu/
services/pdz/start
[92]
BOND Biomolecular 
Object Network 
Databank
An interaction database that 
includes high-throughput data 
submissions and manually 
curated information from 
literature. 
Cytoscape bond.unleashedinfor-
matics.com
[93]
BioGRID General Reposi-
tory for Interac-
tion Datasets
A repository for protein and 
genetic interactions contributed 
by the community. 
Osprey www.thebiogrid.org [94]
OPHID Online Predicted 
Human Interac-
tion Database
Database with known protein-
protein interactions from 
human and predicted protein-
protein interactions from model 
organisms. 
Y ophid.utoronto.ca/
ophid
[95]
PIP Potential Interac-
tions of Proteins
Predicted protein-protein 
interactions derived from 
homology with experimentally 
known interactions from other 
species. 
Y bmm.cancerre-
searchuk.org/~pip
[96]
MPPI MIPS mammalian 
protein-protein 
interaction 
database
Published experimental protein 
interaction data in mammals
Y mips.gsf.de/proj/ppi [97]
(Continued)387
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Table 3. (Continued)
Database Full name Comments Visualization 
capability
Website Ref
HPID Human Protein 
Interaction 
Database
Human protein interaction 
information and infer interac-
tions between submitted 
proteins. 
WebInter-
Viewer
www.hpid.org or 
wilab.inha.ac.kr/hpid
[98]
InterDom Database of 
Interacting 
Domains
Putative protein domain 
interactions information. 
N interdom.lit.org.sg [99]
STRING Search Tool for 
the Retrieval of 
Interacting 
Proteins
Database of known and 
predicted protein-protein 
interactions. 
Y string.embl.de [100]
information is provided in each pathway, including 
the cellular locations of the proteins, the types of 
physical interactions including molecular interac-
tion, biochemical reaction, catalysis and transport, 
and post-translational protein modiﬁ  cations. The 
original citations, experimental evidences, and 
links to other databases are also listed. Gene 
expression data can also be visualized in the con-
text of Cancer Cell Map pathways using the 
Cytoscape network visualization and analysis 
software
60.
Human Protein Reference Database
The HPRD (Human Protein Reference Database) 
contains ten cancer signaling pathways and ten 
immune signaling pathways which are graphically 
visualized in GenMAPP pathway maps
54,61. The 
HPRD also offers the ﬂ  exibility for investigators 
to reﬁ  ne their search of interested protein by mul-
tiple criteria, including molecular class from GO, 
domain name, motif, site of expression, length of 
protein sequence, molecular weight, and disease 
association (e.g. ovarian cancer and breast cancer). 
The protein domain architecture is graphically 
visualized with description of the domains and 
motifs within the queried protein. Post-transla-
tional modifications, protein interactions, and 
disease type are linked to PubMed, OMIM, Swiss 
Prot, Gene-Prot, Entrez Gene, or pathways within 
the HPRD. Individual genes within the pathway 
map are also linked to biologically relevant data-
bases. Results from pathway analysis and HPRD 
entries can be readily exported. The use of XML 
(extensible markup language) for HPRD entries 
makes this database interoperable with other pub-
lic databases. As with Cytoscape, the development 
of GenMAPP allows users to map microarray data 
onto pathway maps
61.
Reactome
Reactome is a publicly available, peer-reviewed 
resource of human biological pathways.
62 Although 
the primary focus is on H. sapiens, it is now extend-
ing human pathways onto other organisms via puta-
tive orthologs to make them applicable to 21 model 
organisms, including mouse, rat, chicken, puffer 
ﬁ  sh, worm, ﬂ  y, yeast, and E. coli. All the information 
in Reactome is cross-referenced with PubMed, GO, 
and the sequence databases at NCBI, Ensembl, and 
UniProt. Small molecules are linked to ChEBI 
(http://www.ebi.ac.uk/chebi), catalyst activities to 
the GO molecular function ontology, and sub-cel-
lular locations to the GO cellular compartment 
ontology. The OMIM morbid map can be overlaid 
into the reaction map to see which genes have been 
implicated in the disease in the literature. Reactions 
from direct evidence in the literature and indirect 
evidence that are inferred via orthology in other 
species are indicated by color-coding. The Reactome 
SkyPainter tool facilitates the labeling of genes or 
proteins in the reaction maps. Thus, quantitative data 
from microarray experiments can be superimposed 
on Reactome maps to provide visualization and 
exploration in a pathway context.388
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Individual gene, mRNA, and protein
Biological information
Molecular interactions among biological entities
Published articles in literature and data repositories
Natural language processing Text-mining tool
Standard input format
Visualization Maps in Pathway Database
Molecular interaction databases
Genomic, transcript, and protein
sequences
Natural language processing Text-mining tool
Standard output format
Pathway Database knowledgebase
Figure 4. An approach to building pathway databases. Biological knowledgebases are represented as rectangles with squared edges. 
Computational tools for text-mining and language control are represented as ellipses. Molecular interaction and pathway databases are 
represented by rectangles with rounded edges.389
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Table 4. Pathway databases.
Pathway 
databases
Full name Comments Cost Visualization 
capability
Website Ref
KEGG 
pathway
Kyoto Encyclo-
pedia of Genes 
and Genomes 
Pathway
Manually drawn pathway 
maps with different 
organisms. 
Free Y www.genome.ad.jp/
kegg/kegg2.html
[59]
The Cancer 
Cell Map
- Ten human cancer-
related signaling 
pathways. 
Free Cytoscape cancer.cellmap.org/
cellmap
N/A
Reactome - Biological pathways that 
include experimentally 
conﬁ  rmed, manually 
inferred, and electroni-
cally inferred reactions. 
Free Skypainter www.reactome.org [62]
HPRD Human Protein 
Reference 
Database
Ten human cancer 
signaling pathways and 
10 immune system 
signaling pathway. 
Free GenMAPP www.hprd.org [54]
BioCarta Charting Path-
ways of Life
Graphical display of 
known and suggested 
pathways. 
Free Y www.biocarta.com/
genes/index.asp
N/A
STKE Signal Transduc-
tion Knowledge 
Environment
Database of cellular 
signaling pathways. 
Free SVG stke.sciencemag.org [101]
PharmGKB The Pharmaco-
genetics and 
Pharmacoge-
nomics Knowl-
edge Base
Database to explore 
relationships among 
drugs, diseases and 
genes, including their 
variations and gene 
products. 
Free Y www.pharmgkb.org [102]
Panther 
Classiﬁ  ca-
tion System
Protein Analysis 
Through Evolu-
tionary Relation-
ships
Predict protein function 
and contains over 139 
pathways mapped to 
protein sequences. 
Free CellDesigner www.pantherdb.
org/pathway
[103]
MetaCyc Metabolic 
Encyclopedia of 
enzymes and 
pathways
Non-redundant, experi-
mentally determined 
pathways from more 
than 900 different 
organisms. 
Free Y metacyc.org [104]
aMAZE - Molecular interactions 
and cellular processes. 
Free N www.scmbb.ulb.
ac.be/amaze
[105]
CGAP Cancer Genome 
Anatomy Project
Pathways are from 
BioCarta and KEGG. 
Free Y cgap.nci.nih.gov/
Pathways
[106]
INOH 
Pathway 
Database
Integrating 
Network Objects 
with Hierarchies
Pathway database of 
different organisms 
which organize pathway 
objects in an ontology-
based system. 
Free INOH Client 
tool
www.inoh.org N/A390
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Visualization tools
Cross-talk between pathways can complicate the 
graphical representation of observed biological 
interactions. Therefore, visualization tools such as 
Cytoscape
60 and GenMAPP
61 have been developed 
to illustrate molecular interactions intuitively.
Cytoscape
Cytoscape is a software tool for the integration of 
pathways with expression proﬁ  les. It allows the 
querying of networks by using several ﬁ  ltering tools, 
and linking a given network to public databases for 
functional annotations
60. An important feature of 
Cytoscape is its extensible software framework 
which allows users to implement new algorithms 
and network computations. In addition to its use by 
the Cancer Cell Map (described above), Cytoscape 
can also be used in conjunction with other protein 
interaction databases or genetic interaction data-
bases
63,64. Molecular species are represented as 
nodes and intermolecular interactions are linked as 
edges. Different visual properties such as node color, 
shape, and size can be chosen, and subsets of nodes 
and edges can be displayed based on the criteria that 
are selected by the user. Visualization properties and 
analysis parameters are customizable.
GenMAPP
GenMAPP (Gene Map Annotator and Pathway 
Profiler; previously called Gene MicroArray 
Pathway Proﬁ  ler) is a computer program designed 
to display gene expression data in the context of 
biological pathways
61. Based on the quantitative 
data that is loaded, the program will map genes onto 
relevant pathways and the user can set up criteria to 
color code the genes accordingly. GenMAPP visu-
alize data in a ﬁ  le format called “MAPPs”, which 
allow users to organize the genes by their functional 
component. The user has the choice to download 
speciﬁ  c pathways or from the archive of MAPPs at 
www.netpath.org. The MAPPs database is manually 
curated, with interactions derived from textbooks, 
review articles, and public pathway databases. Gen-
MAPP also has the feature to construct and modify 
the pathways by the user, a quality that is not pos-
sible if analyzing pre-existing pathway databases 
like EcoCyc, MetaCyc, and KEGG. Gene identiﬁ  ca-
tion (ID) from GenBank, SWISS-PROT, Gene 
Ontology, or other known databases is used to link 
the gene object on the MAPP to public databases 
like SWISS-PROT or Entrez Gene by selecting the 
gene of interest. In addition, GenMAPP displays 
gene expression levels and provides statistical 
analysis based on the representation of altered genes 
in a given pathway MAPP.
Software Tools to Analyze HTP Data
GoMiner
8,9, MAPPFinder
10, and EASE
65 are soft-
ware tools developed to correlate gene expression 
changes with GO terms to categorize the biological 
processes, cellular components, or molecular 
functions that are statistically affected. However, 
visualization of the pathway networks is challenging 
Table 5. Collection of databases.
Databases Full name Comments Cost Website Ref
Pathguide The Pathway 
Resource List
List about 222 
biological 
pathway data-
bases. 
Free www.pathguide.org [58]
UBiC Bioinfor-
matics Links 
Directory
UBC Bioinformatics 
Centre
Curated links to 
molecular 
resources, tools, 
and databases. 
Free bioinformatics.ubc.ca/
resources/links_directory
[107]
NAR Molecular 
Biology Data-
base Collection
Nucleic Acids 
Research online 
Molecular Biology 
Database Collec-
tion
Provide external 
links to 
sequence, 
structures, and 
pathway data-
bases. 
Free www3.oup.co.uk/nar/
database/subcat/6/25
[108]391
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and complicated. Many software tools have been 
developed for microarray researchers to analyze 
large scale high-throughput data within the context 
of biological pathways, including the above men-
tioned Cytoscape and GenMAPP. Some of the most 
commonly used software tools are listed in Table 6. 
Here, we describe some of the freely available soft-
ware tools that provide graphical representations of 
gene networks.
Pathway Processor
Pathway Processor is designed to visualize whole 
genome microarray data in the framework of 
metabolic networks and provides statistical sig-
niﬁ  cance of the reliability of each differentially 
expressed gene
66. This program displays data based 
on the information from the KEGG pathway data-
base. Pathway Processor is implemented as two 
programs: Pathway Analyzer and Expression Map-
per. Pathway Analyzer is the portion responsible 
for the statistical analysis of pathway signiﬁ  cance, 
while Expression Mapper facilitates the visualiza-
tion of this data on KEGG pathway maps.
Whole Pathway Scope
Whole Pathway Scope (WPS) is a software tool to 
analyze high-throughput microarray experiments 
by referencing pathway or gene information from 
KEGG, BioCarta, and Gene Ontology
67. The inter-
nal database also includes information from the 
Genetic Association Database and MedGene Data-
base to allow users to rapidly identify disease-
associated genes and highlight them inside their 
network diagram or select them for further network 
manipulation. One of the key features is the ability 
to view multiple experiments simultaneously and 
color-code the expression value with its p-value. 
In addition, this software allows users to customize 
their own metabolic pathway and gene groupings 
with the option of using statistical analysis.
Pathway Explorer
Pathway Explorer is a web-based service available 
at https://pathwayexplorer.genome.tugraz.at to 
map expression proﬁ  les of genes onto pathway 
maps extracted from KEGG, BioCarta, and Gen-
MAPP
68. This web-based service reduces the local 
Copy number data
Epigenetics data
Gene expression data
Clustering analysis GO annotation Pathway analysis
e.g. Copy number profiling showing 
        amplification in X numbers of genes. 
e.g. Epigenetic profiling showing 
       hypomethylation in Y genes.
e.g. Gene expression profiling showing
        incresaed in expression in Z genes. 
Copy number data
Epigenetics data
Gene expression data
e.g. Identify common biological 
processes. 
e.g. Identify clusters of samples 
and/or subgroups of genes. 
e.g. Identify pathways these 
genes act upon. 
Identify N genes that show the same direction of change. 
Multidimensional profiling of a cancer genome
Figure 5. Genome-wide integrative analysis to identify pathways disrupted in cancer. Genome-wide analyses including copy number proﬁ  ling, 
epigenetic proﬁ  ling, and transcription proﬁ  ling performed on the same cancer sample could narrow down the number of candidate genes, 
which would in turn help to pinpoint disrupted pathway involved in cancer.392
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requirement for computational resources. It offers 
customizable analysis of the data by analyzing in 
a single or multiple pathways, and a right-tailed 
Fisher’s exact test and false discovery rate analysis 
were applied to determine the signiﬁ  cance of the 
different pathways. Multiple experiments can also 
be displayed simultaneously on a single pathway 
with corresponding expression values. Data is 
linked to publicly available biological databases 
(e.g. the NCBI Entrez cross-database search, 
OMIM, KEGG pathways). The online accessibil-
ity of PathwayExplorer enables visualization of 
DNA or gene expression proﬁ  les within the context 
of biological pathways in a rapid manner.
Future Considerations
The development of various computational tools to 
interrogate biological databases is accelerating the 
process to understand high-throughput genomic 
studies. However, these new tools pose new chal-
lenges, and one must be cautious about the limita-
tions and errors associated with various databases. 
For example, it has been reported that when a par-
tial Enzyme Commission (EC) number, which is a 
combination of four digits to annotate enzymatic 
activities without the fourth digit, is assigned to a 
gene, several pathway databases have used partial 
EC number annotations and inaccurately assigned 
them to a set of reactions that are associated with 
the same partial EC number under each orthology 
group
69. Pathway database users should be aware 
of the possible inherent problems associated with 
any databases due to the variable quality of the 
published data. Comprehensive examination of the 
literature, as well as additional experimental valida-
tion, should be used to conﬁ  rm any ﬁ  ndings. Cross-
platform integrative analysis of genomics, 
epigenomics, and transcriptional proﬁ  ling will offer 
a deeper understanding of the biological complex-
ity underlying disease processes (Fig. 5)
70. The 
current challenge is to incorporate these data 
together for direct comparison, visualization, and 
analysis in order to identify salient gene candi-
dates
71. Once this is accomplished, the next step 
will be to place these candidates in the context of 
their proper signaling pathways for a given cancer 
type. Ultimately, the software programs used to do 
this should be intuitive to use, provide accurate 
information, allow customizable analyses, and offer 
sophisticated statistical tools. All of these features 
will be essential for characterization of disrupted 395
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gene networks in cancer. This will set the stage for 
rational therapeutic selection based on the underly-
ing genetic realties of a speciﬁ  c tumor
38,41.
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